ICL stock rises about 3% as fertilizer prices cool — what investors are watching next

ICL stock rises about 3% as fertilizer prices cool — what investors are watching next

NEW YORK, December 31, 2025, 11:00 ET — Regular session ICL Group Ltd shares were up about 3.4% at $5.73 in morning trading on Wednesday, after touching $5.75 at the session high. The stock opened at $5.53 and traded as low as $5.55, with about 1.2 million shares changing hands. The move lands as investors gauge pricing signals for crop nutrients heading into 2026, after a late-December pullback in retail fertilizer prices. DTN said seven of eight major fertilizers it tracks were lower in the fourth week of December, including diammonium phosphate (DAP) — a common phosphate fertilizer — down
31 December 2025
Via Transportation stock rises today as VIA trims post-IPO slump in New York trade

Via Transportation stock rises today as VIA trims post-IPO slump in New York trade

NEW YORK, December 31, 2025, 10:45 ET — Regular session Shares of Via Transportation Inc climbed about 3% to $30.38 by late morning on Wednesday, after trading as low as $29.40 and as high as $30.51. About 110,000 shares had changed hands. The bounce matters because Via is still in the early months of life as a public company, when liquidity and valuation can swing sharply on small shifts in sentiment. Investors are also trying to map a contract-heavy public transit business onto a quarterly earnings calendar. Via sells software that helps transit agencies and cities run on-demand shuttles and
31 December 2025
Why TeraWulf (WULF) stock is up today: KBW upgrade flags AI leasing pivot and $1.3B Texas financing

Why TeraWulf (WULF) stock is up today: KBW upgrade flags AI leasing pivot and $1.3B Texas financing

NEW YORK, December 31, 2025, 10:44 ET — Regular session Shares of TeraWulf Inc rose about 4.4% to $11.64 in morning trading on Wednesday after Keefe, Bruyette & Woods upgraded the stock to Outperform and raised its price target to $24 from $9.50. TipRanks The call matters because crypto miners are increasingly being valued as power-and-real-estate plays, not just bets on bitcoin prices. Investors have been looking for steadier revenue streams as bitcoin mining margins swing with token prices, network difficulty and electricity costs. TeraWulf has been pushing deeper into renting out data-center capacity to customers running artificial intelligence workloads,
Polestar stock jumps as BBVA discloses 8.4% stake and Geely backstop details surface

Polestar stock jumps as BBVA discloses 8.4% stake and Geely backstop details surface

NEW YORK, December 31, 2025, 10:37 ET — Regular session Polestar Automotive Holding UK PLC shares rose 4.4% to $20.38 in morning trading on Wednesday after a regulatory filing showed Banco Bilbao Vizcaya Argentaria (BBVA) held an 8.4% stake. The bank reported beneficial ownership of 7,755,946 Class A American Depositary Shares (ADSs) as of Dec. 23 and disclosed a put option arrangement tied to Geely affiliates. SEC The disclosures matter because Polestar’s funding and potential dilution remain central to the equity story, and fresh ownership data can signal how recent capital has been placed. For traders, the terms around new
Molina Healthcare stock rises again after Michael Burry touts insurer; Feb. 5 earnings in focus

Molina Healthcare stock rises again after Michael Burry touts insurer; Feb. 5 earnings in focus

NEW YORK, December 31, 2025, 10:30 ET — Regular session Molina Healthcare Inc shares were up 2.1% at $174.33 by 10:30 a.m. ET on Wednesday, after trading between $170.03 and $176.33 earlier in the session. The move matters because Molina has been highly sensitive to shifts in sentiment after cutting its 2025 profit outlook in October on higher medical costs, particularly in its Affordable Care Act marketplace business. “Approximately half of our underperformance is driven by the Marketplace business,” CEO Joseph Zubretsky said at the time. Reuters Investors are now looking to the company’s next update for signs that medical-cost
Arcutis Biotherapeutics stock pops today as ARQT bucks biotech dip into year-end trade

Arcutis Biotherapeutics stock pops today as ARQT bucks biotech dip into year-end trade

NEW YORK, December 31, 2025, 10:33 ET — Regular session Shares of Arcutis Biotherapeutics Inc rose 3.8% to $29.16 by 10:33 a.m. ET on Wednesday, extending gains in the final U.S. trading session of 2025. The Nasdaq-listed dermatology drugmaker traded between $28.08 and $29.19, with about 181,000 shares changing hands. The move puts ARQT within striking distance of $30 and about 8% below its 52-week high of $31.75, a level closely watched by momentum investors. The stock’s 52-week low stands at $11.14, according to market data. markets.businessinsider.com That relative strength mattered on a down day for risk assets. The biotech
StubHub (STUB) stock ticks up as class-action deadline nears and free-cash-flow questions linger

StubHub (STUB) stock ticks up as class-action deadline nears and free-cash-flow questions linger

NEW YORK, December 31, 2025, 10:00 ET — Regular session StubHub Holdings, Inc. shares were up 0.7% at $14.02 in early New York trading on Wednesday as investors digested a new round of shareholder-law-firm alerts tied to the ticket marketplace’s recent IPO. The notices matter because StubHub’s stock has slid sharply since it began trading in September, keeping legal and disclosure issues in the foreground for a newly public company. They also land as investors focus on cash generation. Free cash flow — the cash a business generates after operating costs and capital spending — is a closely watched yardstick
31 December 2025
DJT stock jumps as Trump Media plans Crypto.com digital tokens for shareholders

DJT stock jumps as Trump Media plans Crypto.com digital tokens for shareholders

NEW YORK, December 31, 2025, 10:02 ET — Regular session Shares of Trump Media & Technology Group Corp. (DJT) rose about 4% on Wednesday after the company said it plans to distribute a new digital token to shareholders in partnership with Crypto.com. The stock was up 3.8% at $13.05 in morning trading, after ranging between $12.52 and $13.47. Reuters The latest crypto-linked plan matters because Trump Media has been leaning into financial products to keep investors engaged and broaden its business beyond its social-media app. Traders have been quick to reprice the stock on product headlines, and the company is
New report puts Alabama Power coal ash ponds back under scrutiny near Mobile-Tensaw Delta

New report puts Alabama Power coal ash ponds back under scrutiny near Mobile-Tensaw Delta

NEW YORK, December 31, 2025, 09:30 ET An Inside Climate News investigation published this week said Alabama Power is storing more than 21 million tons of coal ash in an unlined pond at its James M. Barry plant on the Mobile River, near the Mobile-Tensaw Delta. Alabama Power “remains committed to operating in full compliance with environmental regulations,” spokesperson Alyson Tucker said in an email. Inside Climate News The issue is back in focus as regulators and communities push utilities to deal with coal ash — the residue left after burning coal — which can contain contaminants linked to cancer
31 December 2025
FTAI Aviation stock holds near $200 premarket after FTAI Power data-center turbine pivot

FTAI Aviation stock holds near $200 premarket after FTAI Power data-center turbine pivot

NEW YORK, December 31, 2025, 09:15 ET — Premarket FTAI Aviation Ltd shares were down about 0.5% at $196.72 in premarket trading on Wednesday after the aircraft-engine maintenance group launched a new data-center power initiative. The stock ended the prior session up about 14.4% at $197.68. Investing.com The move follows FTAI’s launch of FTAI Power, which the company said will convert widely used CFM56 jet engines into aeroderivative gas turbines for data centers. “Aeroderivative” is industry shorthand for a turbine derived from an aircraft engine. FTAI said it expects production to begin in 2026 for 25-megawatt units and that it
Ultragenyx stock today: RARE steadies premarket after setrusumab Phase 3 miss, FDA gene-therapy filing in focus

Ultragenyx stock today: RARE steadies premarket after setrusumab Phase 3 miss, FDA gene-therapy filing in focus

NEW YORK, December 31, 2025, 09:15 ET — Premarket Ultragenyx Pharmaceutical (RARE.O) shares edged down 0.2% to $22.74 in premarket trading on Wednesday, after finishing Tuesday up 15.5% at $22.78. The stock’s 52-week range is $18.41 to $46.50. StockAnalysis The rare-disease drugmaker is trying to find its footing after a sharp two-day repricing driven by a late-stage clinical setback that hit one of its higher-profile pipeline programs. The next question for investors is whether Ultragenyx can quickly shift attention from a failed bone-disease readout to nearer-term regulatory milestones in gene therapy, while cutting costs to protect cash. Ultragenyx said on
31 December 2025
Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise

Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise

NEW YORK, December 31, 2025, 08:51 ET — Premarket Pfizer Inc shares were little changed in premarket trading on Wednesday after a report showed the drugmaker is leading a new round of U.S. list-price increases for 2026. The stock was down about 0.02% at $24.99, after closing Tuesday at roughly $25.00. The issue matters now because drug pricing has returned to the front burner in Washington, with the Trump administration pressing manufacturers to rein in costs. Year-end is also when many companies set list-price changes that typically take effect in early January. For investors, higher list prices can support revenue

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop